Anaplastic lymphoma kinase–positive primary CNS anaplastic large cell lymphoma in a pediatric patient: illustrative case
Journal of Neurosurgery: Case Lessons · 2025-09-08 · 10 (10)
DOI: 10.3171/case25522 ↗At a glance
Journal article in Journal of Neurosurgery: Case Lessons, published on 2025-09-08. Written by Duygu Dolen Burak and 7 co-authors. Institution: Department of Neurosurgery, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey. Cited 3 times so far (Crossref); 48 references. The full text is freely available (open access, CC BY-NC-ND 4.0).
Abstract (original language)
BACKGROUND Anaplastic lymphoma kinase (ALK)–positive primary CNS anaplastic large cell lymphoma (ALCL) is an extremely rare pediatric malignancy. Its radiological appearance often mimics infectious or glial lesions, complicating diagnosis and delaying treatment. OBSERVATIONS The authors report the case of a 10-year-old immunocompetent female who presented with absence seizures and vomiting. Brain MRI revealed a left frontal lesion with peripheral contrast enhancement and diffusion restriction, suggestive of a cerebral abscess. She was started on antibiotics and underwent resection. Histopathology confirmed ALK-positive primary CNS ALCL. The patient was treated with NHL-BFM (non-Hodgkin lymphoma–Berlin-Frankfurt-Münster) chemotherapy, the ALK inhibitor lorlatinib, and focal cranial radiotherapy (18 Gy/22 fractions). She remains in complete remission at 18 months. A systematic review of 15 pediatric ALK-positive CNS ALCL cases revealed male predominance, supratentorial location, and inconsistent treatment protocols. Methotrexate-based chemotherapy was most common treatment; the role of radiotherapy and surgery varied. LESSONS ALK-positive primary CNS ALCL should be considered in the differential diagnosis of pediatric intracranial masses with atypical imaging. Early histological confirmation is essential. While chemotherapy remains central to treatment, targeted therapies and radiation-sparing approaches require further investigation to improve outcomes and reduce long-term morbidity in children. https://thejns.org/doi/10.3171/CASE25522
Subjects
Author keywords
Authors and institutions
- Department of Neurosurgery, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
- Department of Neurosurgery, Hakkari State Hospital, Hakkari, Turkey.
- Department of Pathology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
- Department of Pediatric Hematology and Oncology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
ORCID profiles: Duygu Dolen Burak, Cafer Ikbal Gulsever, Gokcen Unverengil, Gulcin Yegen
Cite
APA
Dolen Burak, D., Gulsever, C. I., Poyraz, A., Unverengil, G., Yegen, G., Erbas, G., Unal, T. C., & Sencer, A. (2025). Anaplastic lymphoma kinase–positive primary CNS anaplastic large cell lymphoma in a pediatric patient: illustrative case. Journal of Neurosurgery: Case Lessons, 10(10). https://doi.org/10.3171/case25522
Vancouver
Dolen Burak D, Gulsever CI, Poyraz A, Unverengil G, Yegen G, Erbas G, et al. Anaplastic lymphoma kinase–positive primary CNS anaplastic large cell lymphoma in a pediatric patient: illustrative case. Journal of Neurosurgery: Case Lessons. 2025;10(10). doi:10.3171/case25522
BibTeX
@article{DolenBurak2025,
author = {Dolen Burak, Duygu and Gulsever, Cafer Ikbal and Poyraz, Alperen and Unverengil, Gokcen and Yegen, Gulcin and Erbas, Gulcan and Unal, Tugrul Cem and Sencer, Altay},
title = {Anaplastic lymphoma kinase–positive primary CNS anaplastic large cell lymphoma in a pediatric patient: illustrative case},
journal = {Journal of Neurosurgery: Case Lessons},
year = {2025},
volume = {10},
number = {10},
doi = {10.3171/case25522}
}
EUVIMED